FBP1 and cancer: Considering that FBP1, as a gluconeogenic regulatory enzyme, has been shown to play an important role in the impairment of aggressive phenotypes in various cancers through the metabolic switch from glycolysis to oxidative phosphorylation (OXPHOS), Pan et al.